Aptevo Therapeutics Inc (NASDAQ:APVO)

Delayed Data
As of Jun 23
 -0.46 / -1.96%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Aptevo Therapeutics Inc have a median target of 64.00, with a high estimate of 69.00 and a low estimate of 50.00. The median estimate represents a +178.75% increase from the last price of 22.96.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Aptevo Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.94%
Growthannually 20.87%


Growthquarterly -62.83%
Growthannually 61.76%
Key to the earnings and sales forecast charts.